The Patent Finder

Terms ending in 2035

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,789,254Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,821,123Auto-Injector
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 11,426,359Method for Adjusting the Release of Active Agent in a Transdermal Delivery System
In force
 · High confidence
LTS Lohmann Therapie-Systeme AGIn forceHigh confidence
US 10,342,925Auto-Injector
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
US 10,975,066Bis-Heteroaryl Derivatives as Modulators of Protein Aggregation
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
US 10,202,405Fused Pentacyclic Imidazole Derivatives
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 10,906,919Fused Pentacyclic Imidazole Derivatives
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 10,705,094TNF Receptor Signaling Modulator Assay
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 10,883,996Methods of identifying signaling modulators of the trimeric TNFa
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 10,969,393Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
3 more term ends in 2035 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
1 of these is in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited